In April 2001, Pharmacia Corporation (Peapack, New Jersey) announced the discontinuation of its U.S. production of spectinomycin (Trobicin®)* and that its remaining inventory would expire on June 30, 2001.1 Since then, examination of the inventory has revealed that, although some lots of the bacteriostatic water packaged with the spectinomycin have expired, the spectinomycin powder has a shelf-life beyond June 30. The Food and Drug Administration has approved Pharmacia's request to remove the bacteriostatic water and to relabel the current inventory of spectinomycin to expire on December 31. To obtain spectinomycin or to verify whether a spectinomycin lot may continue to be used, contact Wendy Johnson, Pharmacia Corporation, telephone (800) 976-7741, extension 30110; fax (800) 852-6421.
Pharmacia is planning to resume U.S. spectinomycin production later in 2001. When new spectinomycin is available, it will be distributed again through the usual wholesale distribution network.
Update on Spectinomycin Availability in the United States. JAMA. 2001;286(11):1308-1309. doi:10.1001/jama.286.11.1308-JWR0919-3-1